Page last updated: 2024-10-30

losartan and Neointima

losartan has been researched along with Neointima in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Neointima: The new and thickened layer of scar tissue that forms on a PROSTHESIS, or as a result of vessel injury especially following ANGIOPLASTY or stent placement.

Research Excerpts

ExcerptRelevanceReference
"Losartan treatment improved PVS-associated pulmonary hypertension and intimal hyperplasia and might be a beneficial prophylactic therapy for patients at high risk of developing PVS after pulmonary vein surgery."3.80Losartan ameliorates "upstream" pulmonary vein vasculopathy in a piglet model of pulmonary vein stenosis. ( Caldarone, CA; Coles, JG; Fu, YY; Ide, H; Kato, H; Maynes, JT; Teichert, AM; Weisel, RD; Zhu, J, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhu, J1
Ide, H1
Fu, YY1
Teichert, AM1
Kato, H1
Weisel, RD1
Maynes, JT1
Coles, JG1
Caldarone, CA1

Other Studies

1 other study available for losartan and Neointima

ArticleYear
Losartan ameliorates "upstream" pulmonary vein vasculopathy in a piglet model of pulmonary vein stenosis.
    The Journal of thoracic and cardiovascular surgery, 2014, Volume: 148, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Antigens, CD; Cadherins; Constri

2014